Neumora Therapeutics, Inc.
NMRA
$1.84
-$0.13-6.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.66% | -49.74% | -41.45% | -41.01% | -32.25% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 52.11% | -8.72% | 39.07% | -5.72% | -70.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -91.69% | -80.75% |
| Total Current Assets | -39.33% | -49.20% | -44.04% | -42.44% | -34.34% |
|
|
|||||
| Total Current Assets | -39.33% | -49.20% | -44.04% | -42.44% | -34.34% |
| Net Property, Plant & Equipment | -84.33% | -85.90% | -87.49% | -68.16% | -57.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -75.43% | -- | -- |
| Total Assets | -39.73% | -49.56% | -44.66% | -42.97% | -36.12% |
|
|
|||||
| Total Accounts Payable | 2.18% | -91.01% | -40.48% | -29.49% | 881.31% |
| Total Accrued Expenses | 17.06% | 9.77% | 10.65% | 34.78% | 15.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -84.67% | -90.67% | -95.26% | -73.13% | -45.15% |
| Total Finance Division Other Current Liabilities | -- | -58.65% | -33.83% | -8.27% | -4.32% |
| Total Other Current Liabilities | -- | -58.65% | -33.83% | -8.27% | -4.32% |
| Total Current Liabilities | 8.58% | -18.59% | -8.51% | 15.34% | 19.02% |
|
|
|||||
| Total Current Liabilities | 8.58% | -18.59% | -8.51% | 15.34% | 19.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -85.81% |
| Total Liabilities | 191.48% | 43.63% | 76.38% | 10.58% | 10.28% |
|
|
|||||
| Common Stock & APIC | 4.36% | 3.95% | 4.47% | 5.22% | 5.26% |
| Retained Earnings | -25.01% | -26.60% | -30.90% | -34.08% | -34.66% |
| Treasury Stock & Other | -- | -91.43% | 91.98% | 97.97% | 181.58% |
| Total Common Equity | -63.82% | -58.79% | -52.03% | -46.21% | -38.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -63.82% | -58.79% | -52.03% | -46.21% | -38.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -63.82% | -58.79% | -52.03% | -46.21% | -38.80% |
|
|
|||||